The largest Insider Buys this week were for AbbVie Inc. (NYSE:ABBV), Keurig Dr Pepper Inc. (NYSE:KDP), Corteva Inc. (NYSE:CTVA) and Fox Corp. (NASDAQ:FOX).
AbbVie Inc. (NYSE:ABBV): Senior Vice President Enterprise Innovation Nicholas Donoghoe bought 7,525 shares
Senior Vice President Enterprise Innovation Nicholas Donoghoe bought 7,525 shares of ABBV stock on Aug. 29 at the average price of $66.19. The price of the stock has increased by 2.16% since.
AbbVie Inc. is an American international pharmaceutical company that focuses on discovering, developing, and marketing both biopharmaceuticals and small molecule drugs. The company was created in 2013 as a spin-off of Abbott Laboratories. The company has a market capitalization of $99.98 billion, and as of Sept. 6 it traded at $67.72.
On Aug. 16 AbbVie Inc. announced that the U.S. Food and Drug Administration has approved RINVOQ for the treatment of adults with moderately to severely active rheumatoid arthritis who have had intolerance to methotrexate. RINVOQ is a 15 mg once-daily oral Janus kinase inhibitor and is expected to be available in the U.S. in late August 2019.
Keurig Dr Pepper Inc. (NYSE:KDP): Chief Human Resources Officer Mary Beth Denooyer bought 6,000 shares
Chief Human Resources Officer Mary Beth Denooyer bought 6,000 shares of KDP stock on Sept. 3 at the average price of $26.85. The price of the stock has increased by 0.04% since.
Keurig Dr Pepper Inc. is an American beverage conglomerate. Its East-coast division sells coffee, beverages, and Keurig brewers. As of July 2018, the company also sells sodas, juices, and other soft drinks from its Dr. Pepper Snapple division in Texas. The company has a market capitalization of $37.79 billion, and as of Sept. 6 it traded at $26.86.
On Aug. 8 Keurig Dr Pepper Inc. reported financial results for the second quarter of 2019 ended June 30. Net sales increased 196% to $2.81 billion from the same quarter prior year and operating income increased 251% to $587 million from the same quarter prior year. Likewise, earnings per diluted share for the quarter increased 120% to $0.22. These results were significantly impacted by the merger of Keurig Green Mountain and Dr Pepper Snapple Group completed in July of 2018.
Corteva Inc. (NYSE:CTVA): Director Klaus A. Engel bought 18,393 shares
Director Klaus A. Engel bought 18,393 shares of CTVA stock on Aug. 30 at the average price of $30. The price of the stock has decreased by 5.37% since.
Corteva Inc. is an American agricultural chemical and seed company. The company was the agricultural unit of DowDuPont prior to being spun off as an independent public company during June of 2019. The company has a market capitalization of $21.26 billion, and as of Sept. 6 it traded at $28.39.
On Aug. 7 Corteva Inc. announced that it will make an investment in Evogene's agriculture biologicals subsidiary, Lavie Bio. Evogene is a biotechnology company that focuses on developing novel products for life science markets. The transaction includes the exchange of all shares of Corteva's wholly owned subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie.
Fox Corp. (NASDAQ:FOX): Chairman Keith Rupert Murdoch bought 500,000 shares
Chairman Keith Rupert Murdoch bought 500,000 shares of FOX stock on Aug. 28 at the average price of $32.06. The price of the stock has increased by 5.65% since.
Fox Corp. is an American television broadcasting company formed from the 2019 acquisition of 21st Century Fox by the Walt Disney Company. Fox Corp. was spun off from 21st Century Fox and its stock began trading on March 19, 2019. The company is owned by the Murdoch family through a family trust with 39% interest. The company has a market capitalization of $21.14 billion, and as of Sept. 6 it traded at $33.87.
On Aug. 7 Fox Corp. reported financial results for the fourth quarter and full year of 2019 ended June 30, 2019. Revenue for the quarter was $2.51 billion, a 5% increase from revenues of $2.39 billion during the same quarter prior year. Income before tax for the quarter was $656, an increase of 10.6% from income before tax of $593 million during the same quarter prior year.
For the complete list of stocks that were bought by their company executives, go to: Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
This article first appeared on GuruFocus.
- Warning! GuruFocus has detected 2 Warning Sign with ABBV. Click here to check it out.
- ABBV 15-Year Financial Data
- The intrinsic value of ABBV
- Peter Lynch Chart of ABBV